AngioDynamics Income Tax Expense from 2010 to 2025

ANGO Stock  USD 9.01  0.11  1.21%   
AngioDynamics Income Tax Expense yearly trend continues to be very stable with very little volatility. Income Tax Expense is likely to grow to about -6.2 M this year. During the period from 2010 to 2025, AngioDynamics Income Tax Expense quarterly data regression pattern had range of 49 M and standard deviation of  11,318,074. View All Fundamentals
 
Income Tax Expense  
First Reported
2001-08-31
Previous Quarter
133 K
Current Value
-110 K
Quarterly Volatility
5.1 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check AngioDynamics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AngioDynamics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.5 M, Interest Expense of 1.7 M or Total Revenue of 246.7 M, as well as many indicators such as Price To Sales Ratio of 0.91, Dividend Yield of 0.0 or PTB Ratio of 1.17. AngioDynamics financial statements analysis is a perfect complement when working with AngioDynamics Valuation or Volatility modules.
  
Check out the analysis of AngioDynamics Correlation against competitors.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

Latest AngioDynamics' Income Tax Expense Growth Pattern

Below is the plot of the Income Tax Expense of AngioDynamics over the last few years. It is AngioDynamics' Income Tax Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AngioDynamics' overall financial position and show how it may be relating to other accounts over time.
Income Tax Expense10 Years Trend
Slightly volatile
   Income Tax Expense   
       Timeline  

AngioDynamics Income Tax Expense Regression Statistics

Arithmetic Mean(19,200)
Coefficient Of Variation(58,949)
Mean Deviation6,035,575
Median(1,871,000)
Standard Deviation11,318,074
Sample Variance128.1T
Range49M
R-Value(0.31)
Mean Square Error123.8T
R-Squared0.1
Significance0.24
Slope(744,564)
Total Sum of Squares1921.5T

AngioDynamics Income Tax Expense History

2025-6.2 M
2024-6.6 M
2023-7.3 M
2022-2 M
2021-3.4 M
2020-4.5 M
2019-1.3 M

About AngioDynamics Financial Statements

AngioDynamics investors utilize fundamental indicators, such as Income Tax Expense, to predict how AngioDynamics Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Income Tax Expense-6.6 M-6.2 M
When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock:
Check out the analysis of AngioDynamics Correlation against competitors.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.59)
Revenue Per Share
7.064
Quarterly Revenue Growth
(0.08)
Return On Assets
(0.06)
Return On Equity
(0.76)
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.